MoneyWorks4Me

Mankind Pharma - Quaterly Results

05 Nov 2024 Evaluate
The revenue for the September 2024 quarter is pegged at Rs. 25297.40 millions, about 11.91% up against Rs. 22604.70 millions recorded during the year-ago period.Net Profit recorded in the quarter ended September 2024 rise to 34.84% to Rs. 6024.40  millions  compared to R. 4467.90 millions in corresponding previous quarter.Operating Profit saw a handsome growth to 8577.90 millions from 6562.50 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 25297.40 22604.70 11.91 49330.00 43527.50 13.33 92648.09 81271.53 14.00
Other Income 1057.60 581.10 82.00 2005.90 1155.50 73.60 2666.38 1627.83 63.80
PBIDT 8577.90 6562.50 30.71 15248.20 12116.50 25.85 25917.44 18601.65 39.33
Interest 19.20 43.10 -55.45 81.80 62.80 30.25 145.70 277.48 -47.49
PBDT 8558.70 6519.40 31.28 15166.40 12053.70 25.82 25771.74 18324.17 40.64
Depreciation 854.20 770.10 10.92 1688.20 1455.20 16.01 3176.06 2695.80 17.82
PBT 7704.50 5749.30 34.01 13478.20 10598.50 27.17 22595.68 15628.37 44.58
TAX 1680.10 1281.40 31.11 2611.30 2332.80 11.94 4361.57 3145.79 38.65
Deferred Tax 367.80 163.00 125.64 215.60 300.80 -28.32 195.98 229.43 -14.58
PAT 6024.40 4467.90 34.84 10866.90 8265.70 31.47 18234.11 12482.58 46.08
Equity 400.60 400.59 0.00 400.60 400.59 0.00 400.59 400.59 0.00
PBIDTM(%) 33.91 29.03 16.80 30.91 27.84 11.04 27.97 22.89 22.22
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..